Comments on the FDA's Draft Guidance for Industry, Guidance for Industry Evaluating the Safety of Antimicrobial New Animal Drugs with Regard to Their Microbiological Effects on Bacteria of Human Health Concern. The comments focused on areas of the guidance that could use clarification or improvement.